This inventor holds 1 USPTO granted patent. Top assignees: University of South Florida, Wisconsin Alumni Research Foundation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,993 
1 out of 4,243 
Years Active: 2016
Title: Hao Hong - Innovator in RGD Mimetic Peptides
Introduction
Hao Hong is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of peptide compounds, particularly in the development of RGD mimetic γ-AApeptides. His work has implications for imaging, diagnostics, and treatment of angiogenesis-related conditions.
Latest Patents
Hao Hong holds a patent for "RGD mimetic γ-AApeptides and methods of use." This patent encompasses various embodiments of RGD mimetic γ-AApeptide compounds, including those capable of binding to an RGD binding site on integrin αβ. The patent details linear, cyclic, and multimeric RGD mimetic γ-AApeptide compounds, along with methods for their production and application.
Career Highlights
Throughout his career, Hao Hong has worked with esteemed institutions such as the University of South Florida and the Wisconsin Alumni Research Foundation. His research has focused on innovative approaches to peptide technology, contributing to advancements in medical applications.
Collaborations
Hao Hong has collaborated with notable colleagues, including Jianfeng Cai and Youhong Niu. Their joint efforts have furthered research in the field of peptide compounds and their applications.
Conclusion
Hao Hong's work in RGD mimetic γ-AApeptides showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new diagnostic and therapeutic methods in treating angiogenesis-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile